. [82] to evaluate the efficacy, safety and tolerability of Cannabidiol being an adjunct therapy together with anti-epileptic drugs to the individuals suffering from tuberous sclerosis complex whose most typical neurological symptom is epilepsy. With this scientific demo study, soon after cure w